Health Care · Laboratory Analytical Instruments

NAUT Nautilus Biotechnology Inc SEC Filings & Insider Trading Activity 2026

company
CIK 180880542 filings

NAUT at a glance

Nautilus Biotechnology Inc (NAUT, SEC CIK 1808805) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on July 28, 2026, an 8-K current report on September 11, 2026 and Form 4 insider filings as recently as June 22, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • As of June 30, 2026, 20 institutional investment managers tracked by SignalX reported holding Nautilus Biotechnology Inc (NAUT) shares worth $20.8 million in 13F-HR filings.
  • The most recent insider open-market sale reported on Form 4 was by AH Equity Partners Bio II, L.L.C. on June 2, 2026 of 4,615,974 shares at $2.35 per share.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Insiders · 90 days
0 buys · 0 sells
No open-market trades
13F holders
20 funds
$20.8M · +5 vs prior quarter
Latest 10-Q
Jul 28, 2026
Quarterly report

SignalX for NAUT

Don't miss the next NAUT filing

  • Alerts as it files. A push when NAUT files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut NAUT, by share count.
  • Ask anything. An AI agent that reads every NAUT filing and answers with sources.

NAUT alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
NAZEM FARZADAJun 18, 2026-
Akinsanya KarenAJun 18, 2026-
McIlwain Matthew SAJun 18, 2026-
Epperly Melissa B,AJun 18, 2026-
Posard Matthew L.AJun 18, 2026-
AH Equity Partners Bio II, L.L.C.SellJun 2, 2026$2.35
AH Equity Partners Bio II, L.L.C.SellJun 2, 2026$2.35
Murphy Matthew B.AMar 2, 2026-

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Net Income-$63.7M-$70.8M-$59.0M
Balance Sheet
Total Assets$305.6M$242.7M$191.1M
Equity$265.4M$208.7M$157.0M
ROE-24.0%-33.9%-37.6%
Per Share
EPS$-0.51$-0.56$-0.47
Cash Flow
Operating CF-$51.7M-$59.1M-$50.7M
CapEx$2.4M$2.1M$1.3M

Source: XBRL data in Nautilus Biotechnology Inc (NAUT)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q2 2026

Aggregate NAUT share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
NAUT shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q2 202620$20.8M
Q1 202615$27.0M
Q4 202514$12.8M
Q3 202516$6.0M
Q2 202517$5.7M
Q1 202518$6.4M
Q4 202413$11.9M
Q3 20249$11.3M
Position changes: Q1 2026 → Q2 2026
Top Buyers
Top Sellers
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 122 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

NAUT filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

8-K current reports

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
8-KSep 11, 2026--
8-KJul 28, 2026--
10-QJul 28, 2026-
4Jun 22, 2026--
4Jun 22, 2026--
4Jun 22, 2026--
4Jun 22, 2026--
4Jun 22, 2026--
8-KJun 18, 2026--
4Jun 4, 2026-
8-KApr 28, 2026--
10-QApr 28, 2026-
4Mar 4, 2026--
4Mar 4, 2026--
4Mar 4, 2026--
4Mar 4, 2026--
4Mar 4, 2026--
4Mar 4, 2026--
10-KFeb 26, 2026-
8-KFeb 26, 2026Analysis-
10-QOct 28, 2025-
10-QJul 31, 2025-
10-QApr 29, 2025-
10-KFeb 27, 2025-
10-QOct 29, 2024-

Related Health Care companies

All Health Care →

NAUT SEC filings: frequently asked questions

Which institutions hold NAUT stock?

As of June 30, 2026, the largest Nautilus Biotechnology Inc (NAUT) holders among the 13F filers tracked by SignalX were BlackRock ($5.0 million), Vanguard Capital Management LLC ($4.8 million), Citadel Advisors LLC ($3.5 million), Renaissance Technologies LLC ($1.3 million), JPMorgan Chase & Co ($1.1 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What are the latest NAUT SEC filings?

Nautilus Biotechnology Inc (NAUT) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on July 28, 2026, an 8-K current report on September 11, 2026 and a Form 4 insider filing on June 22, 2026.

What is NAUT's SEC CIK number?

Nautilus Biotechnology Inc (NAUT)'s SEC Central Index Key (CIK) is 1808805. EDGAR lists every NAUT filing under that number.

Ask anything about NAUT

The research agent reads NAUT's filings, financials, insider trades and 13F holders, then answers with sources.